关节多动性,自主功能障碍,胃肠功能障碍和自身免疫标记:临床关联和对静脉免疫球蛋白治疗的反应
Pankaj J Pasricha1, Megan McKnight2, Luisa Villatoro1
1Mayo Clinic, Scottsdale, Arizona, USA.
The American journal of gastroenterology
|June 24, 2024
概括
在患有慢性神经胃肠病学症状的患者中,自身免疫标志物和自主功能障碍是普遍存在的,特别是那些患有关节高流动性/高流动性谱系障碍的患者. 静脉注射免疫球蛋白 (IVIG) 在治疗中表现有前途,需要进一步进行受控试验.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 慢性神经胃肠病学症状往往缺乏明确的病因.
- 在这些患者中,自身免疫标志物 (AIM) 和自主功能障碍越来越多地被发现.
- 关节高移动性/高移动性谱系障碍 (JH/HSD) 可能与这些情况有关.
研究的目的:
- 研究患有慢性神经胃肠道症状的患者中AIM和自主功能障碍的流行情况.
- 探索AIM,自主功能障碍和JH/HSD之间的关系.
- 评估静脉注射免疫球蛋白 (IVIG) 在治疗这些患者中的疗效.
主要方法:
- 根据自身免疫诊断和血清标志物状态定义的AIM阳性.
- 研究了三个队列:回顾性 (n=300),前性验证 (n=133) 和治疗 (n=40).
- 给治疗队列开放的IVIG.
主要成果:
- AIM阳性为40% (追溯) 和29% (前性),主要是自身炎症性疾病.
- 有AIM阳性的患者表现出较高的C反应蛋白,心血管自主功能障碍,小纤维神经病变和HLADQ8阳性.
- 患有JH/HSD的患者有更高的AIM率和更严重的自主/GI症状. IVIG改善了症状,但不良事件发生率为62%.
结论:
- 在无法解释的胃肠道症状中,AIM和自主功能障碍很常见,特别是在JH/HSD中.
- IVIG显示了潜在的治疗益处,但需要进行受控试验来确认.
- 对自身免疫,自主和JH/HSD因素的警在神经胃肠道疾病中至关重要.
相关概念视频
Autoimmune Disorders
415
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
415
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125


